Description
A new long-acting glucagon-like peptide-1 (GLP-1) analogue from Novo Nordisk for glycemic control in adults with type 2 diabetes who have received metformin and/or sulfonylureas in addition to diet control and exercise. And reduce the risk of major cardiovascular adverse events (cardiovascular death, nonfatal myocardial infarction, or nonfatal stroke) in adults with type 2 diabetes with cardiovascular disease.
- Lose Weight
- Ozempic
- Removal Fat
Production Capacity:
222222
Delivery Timeframe:
Immediate
Incoterms:
Not informedPackaging Details:
Not informed
More about
hebei Eminent technology co.,ltd
10-50
Employees
500K - 1M
Sales volume (USD)
100%
% Export sales
Year
Established
Business type
- Industry / Manufacturer
- Representative / Agent
- Distributor / Wholesaler
Keywords
- 玻尿酸
- 蛋白线
- 美容产品
Contact and location
- youki liu
- +86 xxxxxxxx
- shijiazhuang / | China